Detalles de la búsqueda
1.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34320176
2.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654660
3.
IL-17A-producing CD8+ T cells promote PDAC via induction of inflammatory cancer-associated fibroblasts.
Gut
; 72(8): 1510-1522, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759154
4.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
5.
Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients less than 60 years of age: a prospective phase II study
Haematologica
; 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941409
6.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37592092
7.
A German-Wide Systematic Study on Mobilization and Collection of Hematopoietic Stem Cells in Poor Mobilizer Patients with Multiple Myeloma prior to Autologous Stem Cell Transplantation.
Transfus Med Hemother
; 50(6): 475-490, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089497
8.
Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study.
Transfus Med Hemother
; 50(5): 403-416, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37899991
9.
[Clonal hematopoiesis: causes and clinical implications]. / Klonale Hämatopoese Ursachen und klinische Implikationen.
Z Gerontol Geriatr
; 56(1): 65-72, 2023 Feb.
Artículo
en Alemán
| MEDLINE | ID: mdl-36662242
10.
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidence.
Eur J Nucl Med Mol Imaging
; 49(9): 3247-3256, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320386
11.
Assessment of Early Therapy Response of Non-Hodgkin's and Hodgkin's Lymphoma Using B-Mode Ultrasound and Dynamic Contrast-Enhanced Ultrasound.
J Ultrasound Med
; 41(8): 2033-2040, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34846074
12.
Maintenance therapy for FLT3-ITD-mutated acute myeloid leukemia.
Haematologica
; 106(3): 664-670, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33472354
13.
[Potential of ultrasound in allogeneic stem cell transplantation and transplant-related complications]. / Potenzial des Ultraschalls bei allogener Stammzelltransplantation und transplantationsassoziierten Komplikationen.
Z Gastroenterol
; 59(4): 336-344, 2021 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-33634439
14.
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol
; 95(7): 824-833, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32279331
15.
Value and Diagnostic Accuracy of Ultrasound-Guided Full Core Needle Biopsy in the Diagnosis of Lymphadenopathy: A Retrospective Evaluation of 793 Cases.
J Ultrasound Med
; 39(3): 559-567, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31584214
16.
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(4): e128-e140, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30658222
17.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514803
18.
Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens.
Biol Blood Marrow Transplant
; 24(2): 276-281, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29037891
19.
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Blood
; 126(1): 42-9, 2015 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25918346
20.
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Lancet Oncol
; 16(16): 1691-9, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26549589